Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review

AS Menezes Júnior, ALG França-e-Silva… - International Journal of …, 2023 - mdpi.com
Atrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the
atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct …

[HTML][HTML] Predisposing and Overall Effects of Reproductive Hormones on Breast Cancer: A Review

AK Sarda, SD Jogdand - Cureus, 2023 - ncbi.nlm.nih.gov
Cancer, the second leading cause of mortality worldwide, has been the subject of extensive
and quickly changing scientific study and practice. Cancer remains a mystery despite the …

Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation

LL Zhang, WH Lin, CY Di, HT Hou… - Journal of the …, 2024 - Am Heart Assoc
Background Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is
associated with serious complications. This study investigated the metabolic biomarkers …

Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus

O Pankova, O Korzh - Wiener Medizinische Wochenschrift, 2024 - Springer
Background This study aimed to evaluate plasma relaxin‑2 (RLN-2) levels in patients with
arterial hypertension (AH) and their relationships with clinical and laboratory parameters …

Risk factors for incident heart failure and atrial fibrillation in an elderly population: The role of cardiac conduction and heart rate variability

B Ostrowska - 2024 - diva-portal.org
Heart failure (HF) is a clinical syndrome, manifested by symptoms attributable to structural or
functional cardiac abnormalities1. However, a ventricular dysfunction may precede the …

INSL3 suppresses LPS-induced inflammation in N9 microglia cells

D Şaker, G Coşkun, S Polat - Cukurova Medical Journal, 2024 - dergipark.org.tr
Purpose: The G-protein coated receptor (GPCR) family, including the Insulin-Like Peptide 3
(INSL3) receptor, is involved in the Nuclear Factor kappa B (NF-κB)-mediated pathway in …